GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Latest Data & Signals Issued

Signal Type Signal Value Data
Score 0.000 85 days ( -0.260 % )
Last Price $26.98 0 %
High/ Low $26.98 - $26.98 0%
Chg 7 Days N/A $26.98 $26.98
Chg 30 Days N/A $26.98 $26.98
Chg 12 mos 110.78 % $12.80 $26.98
Trend - 3 mos N/A Width: 0 %
Trend - 12 mos 80.11 % Width: 40.70 %
Pred. range - 3 mos N/A - N/A -100.00 % - -100.00 %
Pred. range - 12 mos $46.76 - $65.79 73.32 % - 143.85 %
Short MA avg 3 mos Sell 2023-03-15 - 60 days
Long MA avg 3 mos Sell 2023-04-25 - 32 days
Short/Long MA avg 3 mos Sell 2023-04-25 - 32 days
Short MA avg 12 mos Sell 2023-03-22 - 55 days
Long MA avg 12 mos Sell 2022-07-21 - 223 days
Short/Long MA avg 12 mos Buy 2022-06-22 - 243 days
Pivot Short Sell 2023-06-07 - 2 days
Bollinger Sell 0000-00-00 - N/A days
MACD N/A No Dates Stored For This Signal
Click to get the best stock tips daily for free!

About Myovant Sciences Ltd

Myovant Sciences Ltd Myovant Sciences Ltd., a biopharmaceutical company, develops redefine care for women and for men. The company's lead product is relugolix, an oral, once-daily, small molecule that acts as a gonadotropin-releasing hormone receptor antagonist for the treatment of heavy menstrual bleeding related with uterine fibroids, endometriosis-associated pain, and advanced prostate cancer. It is also developing MVT-602, an oligopeptide kisspeptin agonist, whic... MYOV Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT